Compare CHGG & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHGG | CNXU |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.4M | 102.7M |
| IPO Year | 2013 | 2025 |
| Metric | CHGG | CNXU |
|---|---|---|
| Price | $0.70 | $2.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 522.8K | 293.4K |
| Earning Date | 11-03-2026 | 02-03-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.15 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $376,908,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.52 | $3.05 |
| 52 Week High | $1.56 | $13.66 |
| Indicator | CHGG | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 48.79 | 38.57 |
| Support Level | $0.68 | $3.05 |
| Resistance Level | $0.79 | $5.47 |
| Average True Range (ATR) | 0.05 | 0.50 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 64.63 | 10.69 |
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.